NanoEncryption technology works directly on capsules, tablets, vial caps, and single-use syringes to provide multi-layered security consisting of overt, covert and forensic security features. It protects drugs against counterfeiting and illegal distribution using a single technology.
The overt and covert security features allow dose-level authentication at any point in the supply chain, while NanoCodes provide comprehensive tracing information on every capsule.
The NanoCodes may be associated with an unlimited amount of manufacturer-determined data, including product information (strength and expiry date), manufacturing information (location, date, batch and lot number) and distribution information (country, distributor, wholesaler and chain). They can also be linked to on-package e-pedigree technologies such as radio frequency identification (RFID) and 2-D barcodes, creating a multilayered protective shield of each individual dose from plant to patient.
"Given the concerning rise in counterfeit and illegally diverted medications throughout the world, we wanted to bring value to our customers by helping to protect their brands, companies, and the patients they serve," said Guido Driesen, president and general manager of Capsugel.
In addition to the traditional NanoGuardian model of using a proprietary machine to implement the NanoEncryption technology, Capsugel will offer pre-NanoEncrypted capsule shells to pharmaceutical companies, eliminating any significant additions to their current manufacturing process.
Capsugel says it expects to supply NanoEncrypted capsules by June 2010.
